161 related articles for article (PubMed ID: 30633323)
1. Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?
Cole AP; Fletcher SA; Berg S; Nabi J; Mahal BA; Sonpavde GP; Nguyen PL; Lipsitz SR; Sun M; Choueiri TK; Preston MA; Kibel AS; Trinh QD
Cancer; 2019 Apr; 125(8):1319-1329. PubMed ID: 30633323
[TBL] [Abstract][Full Text] [Related]
2. Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancer.
Washington SL; Gregorich SE; Meng MV; Suskind AM; Porten SP
Cancer Med; 2020 Nov; 9(22):8310-8317. PubMed ID: 32869516
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer.
Krimphove MJ; Cole AP; Fletcher SA; Harmouch SS; Berg S; Lipsitz SR; Sun M; Nabi J; Nguyen PL; Hu JC; Kibel AS; Choueiri TK; Kluth LA; Trinh QD
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):125-136. PubMed ID: 30171227
[TBL] [Abstract][Full Text] [Related]
4. Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis.
Gild P; Wankowicz SA; Sood A; von Landenberg N; Friedlander DF; Alanee S; Chun FKH; Fisch M; Menon M; Trinh QD; Bellmunt J; Abdollah F
Urol Oncol; 2018 Oct; 36(10):469.e1-469.e11. PubMed ID: 30139659
[TBL] [Abstract][Full Text] [Related]
5. Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system.
Schinkel JK; Shao S; Zahm SH; McGlynn KA; Shriver CD; Zhu K
Cancer Epidemiol; 2016 Jun; 42():154-8. PubMed ID: 27161431
[TBL] [Abstract][Full Text] [Related]
6. Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer.
Washington SL; Neuhaus J; Meng MV; Porten SP
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1339-1344. PubMed ID: 31092404
[TBL] [Abstract][Full Text] [Related]
7. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.
Chen F; Bailey CE; Alvarez RD; Shu XO; Zheng W
Gynecol Oncol; 2021 Jan; 160(1):10-15. PubMed ID: 33208254
[TBL] [Abstract][Full Text] [Related]
8. Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013.
Jemal A; Robbins AS; Lin CC; Flanders WD; DeSantis CE; Ward EM; Freedman RA
J Clin Oncol; 2018 Jan; 36(1):14-24. PubMed ID: 29035645
[TBL] [Abstract][Full Text] [Related]
9. Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer.
Sineshaw HM; Ng K; Flanders WD; Brawley OW; Jemal A
Gastroenterology; 2018 Mar; 154(4):906-915.e7. PubMed ID: 29146523
[TBL] [Abstract][Full Text] [Related]
10. Explaining Racial Disparities in Child Asthma Readmission Using a Causal Inference Approach.
Beck AF; Huang B; Auger KA; Ryan PH; Chen C; Kahn RS
JAMA Pediatr; 2016 Jul; 170(7):695-703. PubMed ID: 27182793
[TBL] [Abstract][Full Text] [Related]
11. The Influence of Race on Overall Survival in Patients with Newly Diagnosed Bladder Cancer.
DeDeugd C; Miyake M; Palacios DA; Rosser CJ
J Racial Ethn Health Disparities; 2015 Mar; 2(1):124-31. PubMed ID: 26863249
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in treatment and outcomes among patients with early stage bladder cancer.
Hollenbeck BK; Dunn RL; Ye Z; Hollingsworth JM; Lee CT; Birkmeyer JD
Cancer; 2010 Jan; 116(1):50-6. PubMed ID: 19877112
[TBL] [Abstract][Full Text] [Related]
13. Racial/Ethnic Disparities Associated With Initial Hemodialysis Access.
Zarkowsky DS; Arhuidese IJ; Hicks CW; Canner JK; Qazi U; Obeid T; Schneider E; Abularrage CJ; Freischlag JA; Malas MB
JAMA Surg; 2015 Jun; 150(6):529-36. PubMed ID: 25923973
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
Alimena S; Yang DD; Melamed A; Mahal BA; Worley MJ; Feldman S; Elias KM; Orio PF; Lee LJ; King M
Gynecol Oncol; 2019 Sep; 154(3):595-601. PubMed ID: 31292103
[TBL] [Abstract][Full Text] [Related]
15. Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007).
Mallin K; David KA; Carroll PR; Milowsky MI; Nanus DM
J Urol; 2011 May; 185(5):1631-6. PubMed ID: 21419456
[TBL] [Abstract][Full Text] [Related]
16. Sex and Racial Disparities in the Treatment and Outcomes of Muscle-invasive Bladder Cancer.
Marinaro J; Zeymo A; Egan J; Carvalho F; Krasnow R; Stamatakis L; Lynch J; Hwang J; Williams S; Kowalczyk K
Urology; 2021 May; 151():154-162. PubMed ID: 32810481
[TBL] [Abstract][Full Text] [Related]
17. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
18. Surviving rectal cancer: examination of racial disparities surrounding access to care.
Daly MC; Jung AD; Hanseman DJ; Shah SA; Paquette IM
J Surg Res; 2017 May; 211():100-106. PubMed ID: 28501105
[TBL] [Abstract][Full Text] [Related]
19. Ethnic differences in bladder cancer survival.
Yee DS; Ishill NM; Lowrance WT; Herr HW; Elkin EB
Urology; 2011 Sep; 78(3):544-9. PubMed ID: 21782222
[TBL] [Abstract][Full Text] [Related]
20. Explaining racial disparities in mortality after abdominal aortic aneurysm repair.
Osborne NH; Upchurch GR; Mathur AK; Dimick JB
J Vasc Surg; 2009 Oct; 50(4):709-13. PubMed ID: 19703760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
